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Abstract 
Several mouse models with defects in genes encoding components of the nucleotide excision 
repair (NER) pathway have been developed. In NER two different sub-pathways are known, 
i.e. transcription-coupled repair (TC-NER) and global-genome repair (GG-NER). A defect in 
one particular NER protein can lead to a (partial) defect in GG-NER, TC-NER or both. GG-
NER defects in mice predispose to cancer, both spontaneous as well as UV-induced. As such 
these models (Xpa, Xpc and Xpe) recapitulate the human xeroderma pigmentosum (XP) 
syndrome. Defects in TC-NER in humans are associated with Cockayne syndrome (CS), a 
disease not linked to tumor development. Mice with TC-NER defects (Csa and Csb) are – 
except for the skin – not susceptible to develop (carcinogen-induced) tumors. Some NER 
factors, i.e. XPB, XPD, XPF, XPG and ERCC1 have functions outside NER, like transcription 
initiation and inter-strand crosslink repair. Deficiencies in these processes in mice lead to very 
severe phenotypes, like trichothiodystrophy (TTD) or a combination of XP and CS. In most 
cases these animals have a (very) short life span, display segmental progeria, but do not 
develop tumors. Here we will overview the available NER-related mouse models and will 
discuss their phenotypes in terms of (chemical-induced) tissue-specific tumor development, 
mutagenesis and premature aging features.  
1. Role of NER in the prevention of gene mutations and cancer 
1.1. General introduction into NER 
The genetic information of the cell is not carried by a stable, rigid macromolecule, but by the 
rather vulnerable DNA. Numerous physical and chemical agents of both endogenous as well 
as environmental origin continuously challenge its integrity. Alterations in the DNA of somatic 
cells – from small point mutations affecting only one base pair to large deletions or 
rearrangements – increase with age [1] and are primarily responsible for the age-related 
increase in cancer rate. An immediate effect of DNA damage may be physical interference 
with the cellular machines responsible for gene transcription [2] and [3]. As a result, 
inappropriate changes in gene expression may occur, leading to cellular dysfunction. In 
proliferative cells, DNA damage may additionally block DNA replication and prevent cell 
division [2] and [3]. To counteract such deleterious effects, the cell is equipped with a wide 
variety of genome care taking mechanisms including various DNA repair machineries with 
partially overlapping substrate specificity. The vital importance of DNA repair mechanisms as 
caretakers of the genome is best demonstrated by the consequences of their absence or 
dysfunction in a variety of rare autosomal recessive disorders. A striking example is the repair 
pathway nucleotide excision repair (NER). Three different photosensitive diseases are 
associated with this pathway: (i) xeroderma pigmentosum (XP), (ii) Cockayne Syndrome (CS) 
or (iii) trichothiodystrophy (TTD). The diagnostic features of XP are, besides the 
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photosensitivity: a dry scaly skin (xeroderma), abnormal pigmentation in sun-exposed skin-
areas (pigmentosum), and a 1000-fold increased risk of developing UV-induced skin cancer, 
primarily basal and squamous cell carcinomas and melanomas. Besides this skin cancer 
predisposition, a 10–20-fold increased risk of developing several types of internal cancers 
before the age of 20 has been described [4]. CS and TTD do not show any increased cancer 
risk, but rather attribute hallmarks of premature aging, as manifested by severe mental and 
physical retardation. In addition to the progeroid symptoms observed in both CS and TTD, 
further TTD-features are brittle hair and nails and ichthyosis.  
Complementation studies have shown the involvement of seven genes in XP (XPA through 
XPG) [4] and two genes in CS (CSA and CSB) [5] and [6]. A subset of mutations in XPB, XPD 
and XPG can lead to the combined phenotype of XP and CS. In contrast to classical CS-
patients, these patients are cancer prone [4]. TTD has been associated with mutations in 
XPB, XPD and the recent discovered TFB5 subunit of TFIIH [4] and [7]. To understand how 
mutations in different NER factors, or even how different mutations in the same NER factor, 
cause these different diseases, detailed knowledge on the function of these factors is needed.  
1.2. NER at the molecular level 
Nucleotide excision repair is capable of removing numerous types of helix-distorting lesions, 
including UV-induced photoproducts. Other substrates for NER include reactive oxygen 
species (ROS)-induced 5,8-purine cyclodeoxynucleotides [8] and [9] and bulky lesions, which 
could for example originate from polycyclic aromatic hydrocarbons (as present in tobacco 
smoke and smog). NER functions by a “cut and patch”-like mechanism in which damage 
recognition, local opening of the DNA helix around the lesion, damage excision and gap filling 
occur in successive steps (Fig. 1). NER is composed of two subpathways, global genome 
NER (GG-NER) and transcription-coupled NER (TC-NER), which share the same core 
mechanism but differ in the way lesions are recognized.  
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Fig. 1. Nucleotide excision repair. This figure shows the principle of nucleotide excision repair 
(NER) and its two subpathways, global genome NER (GG-NER) and transcription-coupled 
NER (TC-NER) and the various proteins involved.  
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The first step in GG-NER is damage recognition by the heterodimer XPC/hHR23B [10], [11] 
and [12], which binds with higher affinity to helix-distorting DNA lesions than to non-damaged 
double stranded DNA (dsDNA) [13] and [14]. Since damage recognition is highly dependent 
on the degree of DNA helix distortion, DNA lesions that only mildly disturb the helical structure 
are poorly recognized by XPC/hHR23B and, as a consequence, are inefficiently repaired by 
GG-NER. One such lesion is the UV-induced CPD. GG-NER of this photolesion is greatly 
enhanced by the damaged DNA binding complex (DDB) [15], [16] and [17] composed of 
DDB1 (p125) and DDB2 (p48 or XPE). p48 accumulates at local damage in the absence of 
XPA or XPC [18] and stimulates XPC, XPA and replication protein A (RPA) binding to 
damaged DNA (see below). Moreover, accumulation of XPC on damaged DNA containing 
only CPDs is dependent on p48, suggesting that p48 acts upstream of XPC [19].  
The second mechanism by which NER can be initiated is via damage in the transcribed 
strand of active genes that can arrest the transcriptional machinery. The consequences of a 
stalled RNA polymerase are enhanced for lesions such as CPDs that are slowly (or even not) 
repaired by GG-NER. Repair of such lesions via transcription-coupled NER (TC-NER) [20], 
[21], [22] and [23] is initiated by stalling of an elongating RNA polymerase II upon a lesion 
[24]. The cross-talk between a blocked RNA polymerase and the actual repair reaction, as 
well as the way in which the damage is made accessible, is still a matter of debate. However, 
it is clear that somehow CSA, CSB-and XAB2 gene products are involved in these steps [25], 
[26] and [27]. It has been shown that cell lines mutated for the CSA or the CSB gene or with 
an inactivated XAB2 protein are deficient in performing TC-NER. As a consequence, these 
cells fail to recover RNA synthesis after induction of UV damage, indicating that the 
transcription block remains [3] and [26]. Since damage recognition in TC-NER does not 
depend on helix distortion, but instead on blockage of RNA polymerase II, the spectrum of 
lesions recognized by TC-NER and GG-NER differs. For example, whereas CPDs are poorly 
(and in rodents almost not at all) recognized and repaired by GG-NER, these lesions 
efficiently block transcription and accordingly are efficiently repaired by TC-NER [20]. 
Subsequent to damage recognition by either NER subpathway, the multisubunit transcription 
factor TFIIH and the structure-specific endonuclease XPG are recruited to the lesion [12] and 
[28]. In vitro reconstituted NER requires only the recruitment of XPG at this step [10]. TFIIH 
contains the XPB and XPD proteins that act as 3-5 and 5-3 helicases, respectively, and 
function in local unwinding of the DNA around the lesion [29], [30], [31], [32] and [33]. Initial 
stability of the open structure is guaranteed by the presence of the XPG protein [30] and [34]. 
After verification of the damage by the XPA protein [12], this open structure is further 
stabilized by XPA and RPA [30], [35], [36] and [37]. In a reconstituted system it has been 
shown that XPC-hHR23B is no longer present in this complex [10]. In line with these findings, 
EMSA experiments show that XPC-hHR23B is replaced by XPA and RPA [38]. Finally, the 
ERCC1/XPF endonuclease assembles [10] and [12] and, together with XPG, cleaves 3 and 
5 of the lesion respectively, thereby excising a 24–32 nt single stranded DNA (ssDNA) 
fragment containing the DNA damage [34], [39] and [40]. Using the undamaged strand as a 
template, filling of the ssDNA gap is performed by the DNA replication machinery, consisting 
of RPA, proliferating cell nuclear antigen (PCNA), replication factor C (RFC) and DNA 
polymerases  and [41], [42] and [43]. Finally, the resulting nick is sealed by DNA ligase I 
[44] and [45].  
NER is not a separated module, but is integrated in a network of processes. Also the 
individual NER factors have functions outside the context of NER. Defects in these functions 
might well contribute to the features of XP, CS and TTD patients.  
1.3. Involvement of NER factors in other (DNA repair) processes 
Cells with a mutation in the CSB gene are sensitive for oxidative stress [46], suggesting that 
transcription coupled repair is not restricted to classical NER lesions. Oxidative DNA damage 
is preferentially repaired via the BER pathway. It is, however, largely unclear whether BER 
comprises a TCR component. In fact it is also unknown whether TCR factors like CSA, CSB, 
XPG, XPB, XPD, TFB5 are only needed for removal/back-tracking of the stalled RNA-
polymerase from the damaged site in order to make the lesion accessible to other repair 
factors, or that they are also needed for a transcription coupled repair reaction.  
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The 10-subunit TFIIH complex was originally purified and characterized as a basal 
transcription initiation factor for RNA polymerase II transcribed genes [47]. Three different 
subunits (XPB, XPD and TFB5) of this complex are directly linked to XP, CS and TTD [4] and 
[7]. Indeed, it has been shown that TFIIH is required in both GG-NER and TC-NER [29] and 
[32]. The recent discovered differential phosphorylation of the XPB subunit of TFIIH after UV 
[48], suggests an active switch between the function of TFIIH in repair and transcription. 
Recently, the multifunctionality of TFIIH has been complemented with documented 
involvements in activated RNA polymerase II transcription [49] and [50], in basal transcription 
initiation of rRNA genes by RNA polymerase I [51] and [52] and a possible role of the CAK 
subcomplex in cell cycle [47] and [53]. The ERCC1/XPF complex is a NER factor with 
engagements in interstrand cross-link repair, since deficiency for this structure-specific 
endonuclease causes sensitivity for cross-linking agents. Moreover detailed cell biological 
and molecular studies have shown a function in homologous recombination and perhaps also 
in double strand break repair [54] (and references therein).  
The other endonuclease, XPG has been reported to bind to and stimulate the activity of base 
excision repair proteins [55]. Moreover, in yeast a function of XPG in transcription elongation 
has been suggested [56].  
Specific function of the several factors in the NER reaction, together with the extra non-NER 
related functions, nicely correlates with the different syndromes. Mutations that only hamper 
global genome repair, or are present in the core NER reaction (XPC, XPE, XPA and specific 
subclasses of mutations in XPB, XPD, XPF, XPG) underlie the cancer prone XP. This can be 
explained by the fact that lesions in the total genome, when replicated, can cause mutations 
and thereby underlie cancer. In contrast, mutations that only affect the TCR pathway (CSA, 
CSB) do not lead to an increased cancer incidence, rationalized by the fact that GG-NER is 
still active repairing the bulk of the lesions. Moreover, defects in TCR cause a sensitized 
response to DNA damage (e.g. lower thresholds for sunburn) that likely removes damaged 
cells by apoptosis [57], [58], [59], [60] and [61].  
Defects in TCR (CSA, CSB) will lead to a compromised transcription and thereby might 
disturb the cellular homeostasis. This might lead via p53-dependent and independent 
pathways to cell death (apoptosis) or a permanent cell cycle arrest (senescence). Increased 
cell death, caused by hampered transcription (as a result of defective TCR or caused by 
mutations in the transcription factors themselves) likely cause the progeroid features of CS 
and TTD. Alternatively, increased cell death due to a combination of a NER and an 
interstrand crosslink repair defect can cause similar phenotypes. Finally, the TTD specific 
characteristics (brittle hair, nails and ichthyosis) can be attributed to a reduced stability of the 
TFIIH complex in differentiating cells, causing a transcription defect in cells late in the 
differentiation process.  
2. NER mouse models and their spontaneous phenotypes 
As outlined in the previous section, different factors involved in NER and/or related pathways 
(repair and/or transcription) do have, when affected, an enormous impact on individual 
phenotypes, like cancer and ageing. Most of these phenotypes came apparent from studies 
using mouse models that mimic genetic changes found in patients with defective NER 
functions. A summary of the currently available mouse mutant models and their 
accompanying phenotypes is given in the next section and in Table 1.  
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Table 1.  
























Xpa−/− GG-NER/TC-NER Yes, liver [65], A Yes Liver, kidney, lacZ [66], B Shorter life span, no pathology A 
    No Spleen, Hprt [74]   
 
Xpc−/− GG-NER Yes, lung [72], A Yes Spleen, Hprt [74] Shorter life span A 
mHR23B−/− GG-NER n.a.  n.d.   Very short life span/embroynic lethality [79] 
Xpe 
(DDB2)−/− GG-NER Yes, various [80] n.d.     
 
Csb−/− TCR/transcription No [81] No Liver, kidney, lacZ B Normal life span, mild pathology [81], A 
     Spleen, Hprt [74]   
 
Csa−/− TC-NER No [82] n.d.     
Xpg−/− TCR/transcription n.a.  n.d.   Very short life span, maximum 3 weeks [84] 
Xpgex15 TCR/transcription n.r.  n.d.   Normal life span [86] 
XpgD811stop TCR/transcription No  n.d.   Very short life span, maximum 5 weeks [86] 
XpgE791A TCR/transcription n.r.  n.d.   Normal development [87] 
XpdTTD NER/transcription No [93] and [94] No 
Liver, kidney, 
lacZ B Shorter life span, aging and CR pathology 
[93] and 
[94] 
Xpb−/− NER/transcription n.a.  n.d.   Impaired embryonic development [95] 
Ercc1−/− NER/ICL n.a.  n.d.   Very short life span, maximum 4 weeks [98] and [99] 
Ercc17/− NER/ICL No  Yes Liver, lacZ B Short life span of 4–6 months [99] 
Xpfm/m NER/ICL n.a.  n.d.   Very short life span, maximum 3 weeks [104] 
A: S.W.P. Wijnhoven et al., unpublished results; B: M.E.T. Dollé et al., personal communication; n.a.: not applicable, mice live too short for tumors to develop; 
n.r.: not reported but mice live long enough for tumors to develop; n.d.: not determined; c.r.: caloric restriction. 
a
 Enhanced mutation frequencies when compared to wild type mice.  
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2.1. Mouse models with a defect in GG-NER 
Patients belonging to the XP-A complementation group are in general completely devoid of 
any NER activity. Both GG-NER and TC-NER are defective caused by base substitutions, 
deletions and splice site mutations in the XPA gene, frequently in a compound heterozygous 
manner [62]. To mimic this human XPA null activity, complete knock-out Xpa−/− mice were 
generated by two independent groups [63] and [64]. Xpa−/− mice develop normally, are 
healthy, fertile and show no enhanced mortality up to an age of 18 months [65]. However, 
recently we found that Xpa−/− mice in a pure C57BL/6 genetic background have a slightly 
shorter lifespan than their wild type controls (S.W.P. Wijnhoven, unpublished results). The 
incidence of spontaneous liver tumor development (mostly hepatocellular adenomas, see Fig. 
2) was found to be slightly increased in older Xpa-deficient mice (S.W.P. Wijnhoven, 
unpublished results; [65]). With respect to other aging-related pathology, Xpa−/− mice 
appeared to have the same phenotype as C57BL/6 control wild type mice.  
 
Fig. 2. Hepatocellular adenoma arisen in a male Xpa−/− mouse. Nodular HCA compressing 
adjacent liver tissue spontaneously. Bar represents 500 m.  
After crossbreeding Xpa-deficient mice with the pUR288 lacZ reporter mice, an increased 
level of lacZ mutations was found in livers of 9–16 months old Xpa mice, but not Csb−/−, 
XpdTTD and wild type mice (M.E.T. Dollé, personal communication; [66]). This indicates that 
the accumulation of lacZ mutations (mostly point mutations) in the liver are predictive for 
development of spontaneous tumors at later stages in live, at least in Xpa−/− mice.  
Although no spontaneous neurological abnormalities could be observed in older Xpa-deficient 
mice, a delayed neuromotor recovery and increased cognitive dysfunction was visible 
following experimental brain trauma [67].  
Within GG-NER the XPC protein is, together with HR23B, responsible for recognition of the 
DNA damage (see previous section and [68]). Two independently generated knockout mouse 
models for Xpc [69] and [70] were shown to be viable and to develop normally. Although 
initially, no increased incidence of spontaneous tumors was observed in Xpc-deficient animals 
until the age of one year [69], [70] and [71], a more recent study of Hollander et al. [72] 
showed an enhanced frequency of lung tumor development in Xpc−/− mice. All aged (16–17 
months) Xpc−/− mice (in a mixed background of 75% C57BL/6 and 25% Ola129) developed 
multiple spontaneous lung tumors with a minority progressing to non-small cell lung 
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adenocarcinoma, whereas only 5% of wild type littermates developed such tumors [72]. 
Furthermore, preliminary results of an ongoing lifespan study with Xpc mice show that in a 
pure C57BL/6 background macroscopically lesions are also visible in lungs of Xpc−/− mice 
(S.W.P. Wijnhoven, unpublished results). In addition, and in contrast to previous results [71] 
and [72], we observed for the first time a statistical significant shorter life span for Xpc−/− mice 
and more interestingly, also for Xpc+/− mice as compared to the life span of their wild type 
littermates. Histopathological analyses of tissues of these mice are still ongoing. Allelic 
insufficiency for the Xpc gene has been previously reported with respect to an increased 
predisposition to UV-B-induced skin cancer in aged Xpc+/− mice [73] as well as to 
spontaneous Hprt mutant frequencies in splenocytes [74]. These data can possibly be 
explained by a compromised DNA repair capacity in Xpc+/− cells. However, no enhanced 
lymphoma incidence was reported in Xpc-deficient mice, suggesting that spontaneous Hprt 
mutant frequencies in the spleen are not reliable for prediction of tissue-specific carcinogenic 
responses in mice. In order for tumors to develop, both gene mutations and chromosomal 
rearrangements (that can not be recovered at the Hprt locus) are probably necessary. 
Therefore, lacZ studies (proven to be more predictable for spontaneous tumor development) 
will be performed in the near future in spleen and lung of Xpc mice of different ages to further 
elucidate the spontaneous (cancer) phenotype of Xpc−/− and Xpc+/− mice.  
Another damage recognition factor known to be involved in GG-NER is DDB2/XPE (see Fig. 
1). It is specifically involved in the repair of UV photoproducts, especially CPDs. Furthermore, 
it has recently been shown [75] that in human XPE cells DDB2 first targets and accelerates 
repair of 6-4 PPs as well. Mice with a disruption of this gene (Ddb2−/− mice) were generated 
recently [76], [77] and [78] and apart from the expected skin tumor development upon UV-
irradiation, these mice have a pronounced spontaneous cancer phenotype. A significantly 
reduced life span was found possibly owing to a high incidence of developing “spontaneous” 
tumors at later stages of life (between 20 and 25 months; [77]). The tumor spectrum was quite 
broad, but consistent with the broad expression pattern of DDB2, i.e. lymphomas, lung 
tumors, breast and cervical carcinomas were found [77]. A clear UV cancer-prone phenotype 
was found in Ddb2+/− mice, providing evidence for a gene dosage effect for Ddb2 [76], [77] 
and [78]. In addition, a transgenic mouse model ectopically expressing Ddb2 was generated, 
in which enhanced expression of the protein delayed the tumor phenotype of the mice and 
repair of both CPDs and 6-4PP was improved in dermal fibroblasts [78].  
Finally, mice deficient for HR23B were generated [79]. This protein is found in complex with 
the XPC protein, but its function in NER is unknown. The phenotype of mHR23B−/− mice, i.e. 
impaired embryonic development and a high rate (90%) of intra-uterine or neonatal death, 
completely differs from the “true GG-NER” models [79]. Furthermore, surviving mHR23B−/− 
animals display a variety of abnormalities including retarded growth, facial dysmorphology 
and male sterility, indicating that mHR23B has an important role in development which is 
distinct from XPC and other GG-NER proteins. A possible function of HR23B (and HR23A) 
protein in NER might be the governing of XPC stability via partial protection against 
proteasomal degradation [80].  
In general, the spontaneous tumor-phenotype in the majority of GG-NER deficient mouse 
models suggests that this sub-pathway of NER prevents spontaneous tumorigenesis. 
Interestingly, different tissues seem to be target for tumor development, i.e. liver in Xpa−/−, 
lung in Xpc−/− and a miscellaneous pattern was found in Xpe−/− mice. Apparently, endogenous 
DNA damage in combination with factors that sensor substrate specificity (XPC and XPE) 
determine the ultimate tumor outcome. In the lung preferentially XPC substrates (reactive 
oxygen species, ROS?) are the underlying effectors, whereas other (possibly non-NER) 
substrates, preferentially recognized by the XPE protein, in other tissues are causative to the 
tumor spectrum found in Xpe null mice. As for the liver tumor phenotype in Xpa mice: it might 
be that endogenous (NER-specific) lesions are not repaired any longer in transcribed strands 
of tumor-associated genes, since liver tumors are absent in Xpc mice (only GG-NER 
deficient). These considerations are attractive to initiate further studies on the role of (NER-
specific) DNA lesions in tissue-specific tumorigenesis.  
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2.2. Mouse models with a defect in TC-NER 
Two mouse models for the TC-NER disorder CS, exclusively involving transcription-coupled 
repair, were generated. In Csb-deficient mice, a truncation mutation in the CSB gene of a CS-
B patient [81] was mimicked, while in Csa−/− mice the mouse Csa gene was knocked out by 
interrupting exon 2 [82]. Csb−/− as well as Csa−/− mice appeared to be viable and exhibited all 
of the CS repair characteristics: UV sensitivity, inactivation of TC-NER, unaffected GG-NER 
and inability to resume RNA synthesis after UV exposure. Other human CS features such as 
growth failure and neurological dysfunction were only present in the mouse models in a mild 
form. A recent life span study revealed that although young Csb−/− mice (until the age of 13 
weeks) appeared to have growth characteristics that are quite similar to C57BL/6 controls, a 
minimal weight gain was observed in older Csb−/− mice, resulting in a statistically lower body 
weight compared to wild types, during their entire life span (S.W.P. Wijnhoven, unpublished 
results). Unexpectedly, the median life span of Csb−/− mice was identical to that of C57BL/6 
controls, both in male and female mice (S.W.P. Wijnhoven, unpublished results). 
Furthermore, similar to human CS patients, no enhanced spontaneous tumorigenesis could 
be observed in Csb-deficient mice. In addition, some age-related pathology differences were 
visible in Csb−/− mice, for instance in the kidney (renal karyomegaly, Fig. 3A) and the eye 
(retinal atrophy, Fig. 3B). Apparently, endogenously generated DNA damages in actively 
transcribed genes lead to enhanced pathology in specific target tissues, rather then to tumor 
development as is found in GG-NER defective mouse models (see above).  
 
Fig. 3. Aging-related pathology of Csb−/− mice. (A) Renal karyomegaly. Left panel: pars recta 
of the proximal renal tubules of a wild type C57BL/6 mouse with little variation in nuclear size. 
Middle panel: the same area of a Csb−/− mouse showing an irregular histological picture with 
scattered enlarged and frequently oval shaped nuclei. Right: higher magnification of tubular 
cells with karyomegaly. (B) Atrophy of the retina. Left panel with inner nuclear layer (I), outer 
nuclear layer (II) and rods and cones layer (III) of a young adult C57BL/6 mouse. Below the 
dark stained pigment layer. Mid panel shows slight retinal atrophy as frequently observed in 
old C57BL/6 mice. The three layers (I–III) are smaller and show loss of cellular mass. Right 
panel showing distinctly decreased diameter of the retina in a 2-year old Csb−/− mouse. The 
rods and cones have almost disappeared and decrease in cellularity is obvious in the inner 
and (especially) outer nuclear layers.  
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Recently, a new TC-NER and transcription factor was discovered, XAB2, that associates with 
the CSA, CSB and RNA polymerase II as well as the XPA protein. To further elucidate the 
function of this XAB2 protein in vivo, two different mutations were introduced into the XAB2 
gene in mice. Both deletion mutants, one of the region encompassing the promoter and exons 
1–4 and the other of the C-terminal 162 amino-acids, were embryonic lethal in mice, 
indicating that XAB2 has an essential function in mouse development [83].  
The XPG protein is a structure-specific endonuclease in NER that cleaves 3 of the lesion. 
However, mutations in the human XPG gene can result not only in XP, but also in early onset 
of CS in some patients, pointing to a defect in TCR. This phenotypical heterogeneity was also 
found in the several different Xpg-deficient and mutant mouse models. Complete Xpg-
deficient mice, generated by deletion of exon 3 of the mouse Xpg gene, exhibit postnatal 
growth failure and undergo premature death, similar to human CS features [84]. Further 
examination of cerebellum of these Xpg-deficient mice showed a large number of atrophic 
Purkinje cells, and their dendritic trees were smaller and shorter than in their wild type 
littermates [85]. However, deletion of exon 15 of this gene (Xpgex15, truncation of the last 
183 amino acids) resulted in mice that develop normally. XpgD811stop homozygous mice 
with a C-terminal deletion of 360 amino acids exhibited growth retardation and a short life 
span, mimicking human CS but in a slightly milder form than the Xpg null mutant mice [86]. 
This indicates that the severity of the CS phenotype is influenced by the length of the 
truncated Xpg protein. Introduction of a E719A mutation in exon 11 of the Xpg gene, 
inactivating the endonuclease catalytic site, but leaving the remainder of the protein intact, 
resulted in a normally developing mouse with no obvious defect in class switch recombination 
[87]. In recent reports it has been proposed that XPG is involved in several distinctive 
pathways outside NER, like BER and transcription [88], [89] and [90].  
All together we can conclude that, although XPG seems to have a more or less identical 
function in NER as the ERCC1/XPF protein complex, i.e. incision of a stretch of damaged 
DNA (Fig. 1), the mouse models clearly display different phenotypes (see also below). Further 
studies are needed to elucidate the exact function of XPG in NER and other processes the 
protein is definitely involved in.  
In summary and in contrast to the GG-NER mouse models, it appears that TC-NER-deficient 
mouse models do not have an effect on spontaneous tumorigenesis, which is in keeping with 
the human situation. This finding is further supported in mice by the lack of enhanced 
spontaneous mutagenesis on Hprt in splenocytes [76] and on lacZ in kidney and liver (M.E.T. 
Dollé, personal communication) of aging Csb−/− mice.  
2.3. Mouse models with a defect in NER and transcription 
Important core components within NER are the XPB and XPD helicases which are subunits of 
the TFIIH complex implicated as DNA helix opener in both NER and basal transcription 
initiation. The multi-functionality of both proteins is illustrated by the complex genotype–
phenotype relationship in human NER patients having different mutations in XPD. Site-
specific XPD germ-line mutations can lead to a variety of syndromes; XP, XP combined with 
CS, or TTD (see above and Fig. 1).  
Consistent with the essential role of XPD in basal transcription, mice with a Xpd null allele, 
generated by deleting the helicase domains IV–VI, were embryonic lethal in the pre-
implantation stage [91]. However, the mouse model in which the causative XPDR722W mutation 
of a TTD patient is mimicked is viable [92]. XpdR722W mice further indicated as XpdTTD mice, 
just like the TTD patients, do not suffer from enhanced spontaneous tumorigenesis. In a 
recently published life span study [93], a significantly reduced total number of benign and 
malignant tumors in aging XpdTTD females compared to wild types was observed, especially 
lymphomas and pituitary adenomas. Furthermore and consistent with human TTD, the 
median life span of XpdTTD mice was significantly lower compared to C57BL/6 controls [93] 
and [94]. Although XpdTTD mice display wide-spread, premature segmental multi-system aging 
in various different organs [93] and [94], paradoxically also (life span extending) features 
suggestive of caloric restriction (other than a lower incidence of tumors) were observed in 
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aging XpdTTD mice including lower incidence/severity of de-myelination of the peripheral 
nerve, cataract, thyroid follicular distension, and ulcerative dermatitis [93]. As already 
mentioned before, no enhanced mutagenesis on the lacZ reporter gene was found in liver and 
kidney of XpdTTD mice (M.E.T. Dollé, personal communication).  
XP-B patients are very rare, and two approaches to mimic the splice mutation affecting the 
exon of the XP/CS patient XP11BR were unsuccessful in the mouse and led to embryonic 
lethality. However, a frameshift mutation that mimics the causative XP11BE allele of a human 
patient appeared to be (partly) viable in the mouse. The non-mendalian inheritance again 
indicates that gene mutations in these crucial core components of NER and basal 
transcription easily lead to impaired embryonic development and lethality [95].  
In summary, mice with a defect in both NER and transcription are hard to design. Only one 
clear example is available at present, i.e. the XpdTTD mouse model. The phenotype of these 
mice is that of accelerating aging, suppression of tumorigenesis accompanied by low 
spontaneous lacZ mutation levels.  
2.4. Mouse models with a combined defect in NER, interstrand crosslink and/or double 
strand break repair 
The ERCC1-XPF heterodimer is a structure-specific endonuclease involved in NER but the 
protein complex is also essential for DNA interstrand crosslink (ICL) repair [96] and class 
switch recombination (CSR)[97]. Human ERCC1 mutations have never been described so far, 
but homozygous knockout Ercc1−/− mice, deficient in GG-NER, TC-NER as well as ICL repair, 
are viable, but have a much more severe phenotype than other NER-deficient mice [98] and 
[99], consistent with the additional role of the protein outside NER. Although Ercc1−/− mice 
develop normally, they quickly display severe wasting resulting in death in the fourth week of 
life. The most striking defect of Ercc1−/− mice is liver failure with accelerated hepatocyte 
polyploidy, a feature that can be corrected by administration of an ERCC1 transgene [100]. 
Many of the features of the Ercc1−/− mice are reminiscent of normal mammalian aging, 
including ataxia, kyphosis, ostopenia, weight loss, skin atrophy sarcopenia and hepatocellular 
polyplodization [101]. Recently, it was reported that Ercc1−/− mice also display hematopoietic 
aging as both basal hematopoiesis and reserve capacity under stress were severely reduced 
in these mice, consistent with that found in normal aged mice [102]. However, the premature 
liver polyploidy, as was reported in Ercc1−/− mice, differs from the normal aging-related 
process, as the observed dramatic increased p21 levels in Ercc1−/− livers were absent in livers 
of normal aging mice with the same amount of polyploidy [103]. The combination of a 
knockout allele with a truncated version of Ercc1, missing only seven amino acid residues at 
the C-terminus (Ercc17/−) [99] delays the onset of the premature aging phenotype and 
extends the maximal lifespan to about 4–6 months.  
Mice with a defect in the XPF factor more or less display the same phenotype as found in the 
different Ercc1 models. Xpf-mutant mice were generated by introducing a G-445 mutation 
resulting in a stop codon in exon 8 of the mouse Xpf gene [104]. Although this mutation is 
compatible with normal development in humans, a severe postnatal growth effect was 
observed in Xpfm/m mice, resulting in death approximately 3 weeks after birth. Consistent with 
the phenotype of Ercc1−/− mice, histological examination revealed that livers of Xpfm/m mice 
contained abnormal cells with enlarged nuclei [104].  
LacZ mutation analysis in livers of 23-week old Ercc17/− mice revealed a significant increase 
in both point mutations as well as size-change (translocation/recombination) mutations 
compared to sibling controls (M.E.T. Dollé, personal communication). Since in Xpa−/− mice the 
increase in mutations at older age was caused primarily by an increase of only point 
mutations, the result in Ercc17/− mice reflects their additional defect in ICL repair. Considering 
the mutation types found in the XP models (Xpa and Xpc, see above) compared to those in 
Ercc17/− mice, one might argue that accumulating point mutations preferentially lead to 
cancer, whereas size change mutations will ultimately end up in segmental accelerating 
aging. Support for this hypothesis comes further from a study with aging wild type mice, in 
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which large rearrangements in lacZ preferentially accumulate at later stages of life, even in 
non-tumorous post-mitotic tissue [1].  
2.5. Double mutant mouse models 
Finally, several double mutant or knock-out NER mice were developed to gain more insight in 
the relationship between the different NER (-associated) processes. For example, double 
mutant mice for CS and XP, i.e. Csb/Xpa and Csb/Xpc mice display very severe growth 
impairment, suffer from neurological problems and die before weaning [95] and [105]. 
Furthermore, a recent study with Xpg/Xpa double mutant mice revealed the same severe 
phenotype of growth retardation and a very short life span, suggesting that XPG can have 
functions similar to CSB [106]. Probably CSB (and XPG) are involved in additional 
transcription-coupled processes. The XpdTTD/Xpa double mutant was found to be compatible 
with normal embryogenesis, but was associated with increased neonatal lethality, suggesting 
that the mice had a reduced tolerance to stress [94]. The life span of this mouse model is only 
3 weeks encompassing a greatly accelerating aging phenotype. In general it can be 
concluded that when pure DNA repair defects, as observed in Xpa and Xpc mice, are 
combined with (mild) defects in transcription initiation (XpdTTD) or transcription elongation 
(Csb), the original cancer phenotype of the XP models is greatly suppressed and replaced by 
phenotypes that are suggestive for accelerated segmental aging. A clear example that 
deficiency in TCR is suppressive to tumor development was recently found in cancer-
predisposed Ink4a/ARF mice. Development of lymphomas and fibrosarcomas was found to 
be clearly reduced (60% reduction) after crossing Ink4a/ARF mice with Csb-deficient mice 
[107].  
3. Tissue-specific mutagenic and carcinogenic effects in NER-deficient mice after 
external exposure 
A defect in GG-NER results in a spontaneous tumor phenotype, whereas defects in TC-NER, 
NER/transcription and NER/ICL repair do not. To gain more insight into the effect of a defect 
in the NER pathway(s) on carcinogen-induced tumorigenesis, NER deficient mouse models 
were exposed to genotoxic carcinogens. These studies are, for obvious reasons, restricted to 
the viable NER mouse models, like mice deficient or mutant for Xpa, Xpc, XpdTTD, Xpe, Csa 
and Csb. The tissue-specific mutagenic and carcinogenic responses in skin, liver, urinary 
bladder, spleen, lung and other tissues will be discussed below and are summarized in Table 
2.  
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Table 2.  


















Skin Xpa−/− UV radiation Yes [63] and [64]   
 Xpc−/− UV radiation Yes [69] and [73]   
 XpdTTD UV radiation Yes [110]   
 Xpe−/− UV radiation Yes [76]   
 Csa−/− UV radiation Yes [82]   
 Csb−/− UV radiation Yes [81]   
 Xpa−/− DMBA paint Yes [63] and [64]   
 XpdTTD DMBA paint Yes [110]   
 Xpe−/− DMBA paint No [76]   
 Csb−/− DMBA paint Yesb [81]   
 
Liver Xpa−/− AFB1 i.p. injection Yes [124]   
 Xpa−/− 2-AAF diet Yes [125] and [126] Yes, LacZ 
[125] and 
[126] 
 Csb−/− 2-AAF diet No [126] Yes, LacZ [126] 
 Xpc−/− 2-AAF diet Yes [126] Yes, LacZ [126] 
 Xpc−/− AAF i.p. injection Yes [127]   





 2-AAF diet No [125] and [126] No 
[125] and 
[126] 
 Xpc−/− 2-AAF diet No [126] Yes, LacZ [126] 
 Csb−/− 2-AAF diet No [126] No [126] 
 
Spleen Xpa−/− B[a]P gavage Yes [67] and [130] 




 Csb−/− B[a]P gavage No [134] No, LacZ and yes, Hprtc [134] 
 
Lung Xpa−/− B[a]P intratracheal Yes [135]   
 Xpa−/− B[a]P gavage No [132] No [132] 
 Xpa−/− B[a]P diet No [136] No [136] 
 Xpc−/− N–OH–AAF i.p. injection Yes [127]   
 Xpc−/− AAF i.p. injection Yes [127]   
DMBA: 7,12-dimethylbenzanthracene; B[a]P: benzo[a]pyrene; AFB1: aflatoxin B; AAF: 
acetylaminofluorene. 
a
 As compared with untreated control mice. 
b
 Only significant in tumor yield, but not in latency time. 
c
 Hprt mutant frequencies were only measured in spleen.  
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3.1. Skin 
NER disorders are characterized by hypersensitivity of the skin to sunlight. Furthermore, 
patients with XP develop skin cancers on exposed sites, whereas CS and TTD patients do 
not. From UV studies in NER-deficient mice it became apparent that – like XP patients – Xpa, 
Xpc and Xpe-deficient mice are susceptible to UV-induced skin cancer [63], [64], [73], [76], 
[78], [108] and [109]. However, in contrast to patients, the XpdTTD, Csa−/− and Csb−/− models 
also appeared more susceptible to develop UV-induced cancer than their littermate controls 
[81], [82] and [110], although a higher cumulative dose and a longer latency time was 
required as compared with Xpa−/− or Xpc−/− mice [82] and [111]. This indicates that – like 
spontaneous tumorigenesis – efficient GG-NER is more important than efficient TC-NER in 
the protection against UV-induced skin tumor development. The discrepancy between mouse 
and human CS and TTD could be related to the more efficient repair of cyclobutane 
pyrimidine dimers (CPDs) by GG-NER in human skin fibroblasts compared to rodents [112] 
and [113].  
In contrast to mice, GG-NER in humans is possibly able to compensate for a defect in TC-
NER, leading to unchanged cancer predisposition in TTD and CS patients. In addition, TTD 
and CS patients have a reduced life span and frequent hospitalization might protect them 
from exposure to sunlight.  
To study the effect of a NER deficiency on UV-induced mutagenesis and carcinogenesis in 
vivo, several mutation studies have been performed at the p53 and Hras gene of UV-induced 
skin tumors in NER-proficient and -deficient mice. UV-induced skin tumors in NER-proficient 
mice expressed a very typical mutation spectrum at p53. The great majority of the mutations 
are found at dipyrimidine sites at the non-transcribed strand (NTS) [114], [115], [116], [117], 
[118] and [119]. In NER-deficient mice, the prevalence of p53 mutations in the TS versus NTS 
is dependent on the specific pathway which is absent. Tumors of Xpc-deficient mice 
predominantly carry mutations in the NTS [115] and [120], whereas tumors of mice deficient 
in the Csb gene show predominantly p53 mutations in the TS [121]. Complete absence of 
NER – as found in Xpa−/− mice – results in the presence of p53 mutations in TS as well as 
NTS (70% and 30%, respectively) [121] and [122]. In addition to p53 mutations, tumors of TC-
NER deficient Xpa and Csb mice – but not WT or Xpc−/− mice – accumulate mutations in the 
Hras gene, exclusively on the TS [121] and [123]. Furthermore, Hras mutations are only found 
in squamous cell papillomas, a tumor type not found in WT or Xpc−/− mice. Evidently, a TC-
NER deficiency results in the formation of Hras mutations and therefore, the formation of 
squamous cells papillomas.  
Next to UV, chemically induced skin tumor analyses have been performed with Xpa−/−, 
XpdTTD, Xpe−/− and Csb−/− mice. These mice were all topically exposed to 7,12-dimethyl-1,2-
benz[a]anthracene (DMBA). Xpa-deficient mice appeared highly sensitive to the toxic as well 
as carcinogenic effects of DMBA [63] and [64]. Toxicity was also observed in TC-NER 
deficient Csb−/− mice, supporting the hypothesis that accumulation of DNA damage at the 
transcribed strand (TS) of genes leads to increased toxicity and apoptosis, resulting in the 
elimination of cells having specifically damage in the TS. In addition, Csb−/− mice were 
susceptible to develop skin tumors, although a higher DMBA cumulative dose and a longer 
latency time than Xpa mice was required, as was found after UV exposure [81]. The tumor 
response of the NER/transcription-deficient XpdTTD mice was intermediate of that observed in 
Xpa−/− and Csb−/− mice [110], suggesting that protection against DMBA-induced skin tumors is 
mainly accomplished by GG-NER. Interestingly, repair of DMBA-induced DNA damage is not 
likely to be mediated by the XPE/DDB2 protein as Xpe-deficient mice showed no increased 
sensitivity to develop DMBA-induced skin tumors as compared to WT mice [76]. Apparently, 
the XPE protein has clear substrate specificity at least in mice, i.e. UV-induced CPDs.  
3.2. Liver 
As described above, Xpa−/− mice are predisposed to develop spontaneous liver tumors, which 
are preceded by elevated levels of lacZ mutations. Upon exposure to carcinogenic agents, 
Xpa−/− mice are even more sensitive to develop hepatocellular tumors. Exposure to aflatoxin 
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B1 (AFB1), p-cresidine as well as 2-acetylaminofluorene (2-AAF) resulted in an increased 
tumor incidence as compared to their WT counterparts [124], [125], [126] and [127]. 
Interestingly, the liver tumor incidence was even higher in Xpc−/− mice than in Xpa−/− mice 
after exposure to 300 ppm 2-AAF (53% versus 25%) and 2500 ppm p-cresidine (78% versus 
36%) [126, H. van Steeg, unpublished results]. In contrast, no liver tumors were found in 
Csb−/− mice [126]. Apparently, a defect in GG-NER is associated with internal cancer 
predisposition in mice after exposure to liver carcinogens. In contrast, a TC-NER deficiency 
seems to have a protective role. Again, this might be attributed to either efficient repair of 
DNA damage at transcribed sequences by GG-NER [128], or by enhanced levels of apoptosis 
in cells which accumulate DNA damage at transcribed sequences. In this respect, it would be 
interesting to analyze the prevalence of mutations in the TS versus NTS of target genes in the 
future. However, the p53 gene is not a suitable candidate since we have previously shown 
that p53 mutations are absent in 2-AAF-induced liver tumors of Xpa−/−mice [125].  
LacZ mutant frequencies were significantly increased in Xpa−/−, Xpc−/− as well as Csb−/−mice 
as compared to their untreated counterparts after 12 weeks of 2-AAF exposure [126] and 
[129]. Interestingly, mutation levels between Xpa−/−, Xpc−/− and Csb−/− livers were all 
comparable, in contrast to the ultimate tumor response. Apparently, lacZ mutant frequencies 
in liver of 2-AAF exposed mice are indicative for exposure to 2-AAF, but not predictive for 
tumor development.  
3.3. Urinary bladder 
2-AAF is an agent which targets both liver and urinary bladder when administrated orally, 
although urinary bladder tumors are found with lower frequencies [126]. No statistic significant 
increase in tumor response was found in 2-AAF-exposed Xpa-, Xpc- or Csb-deficient mice as 
compared with WT mice. Still though, Xpa−/− and Xpc−/−mice developed slightly more tumors 
than Csb−/− mice (incidence of 20%, 21% and 6%, respectively). In contrast, p-cresidine 
exposure in Xpc−/− mice did result in a significantly increased urinary bladder tumor response 
as compared with WT or Xpa−/− mice [H. van Steeg, unpublished results]. This indicates that 
also in bladder, Xpc−/− mice are more sensitive for carcinogen-induced tumor induction, at 
least upon exposure to p-cresidine.  
Mutant frequencies at lacZ upon 12 weeks of 2-AAF exposure were significantly elevated in 
WT, Xpa−/−, Xpc−/− as well as Csb−/− mice [126]. Xpc−/− mice showed the highest levels of lacZ 
mutants, reflecting the GG-NER deficiency in these cells. However, focusing on urinary 
bladder tumor development, the mutant frequencies did not predict tumorigenesis as Csb−/− 
mice showed a mutant frequency comparable with WT and Xpa−/− mice.  
3.4. Spleen 
NER-deficient mice do not develop lymphomas spontaneously. To analyze carcinogen-
induced mutagenic and/or carcinogenic responses in spleen, several exposure studies have 
been performed with benzo[a]pyrene (B[a]P), N-n-butyl-N-nitrosurea (BNU) and DMBA. Of 
these, B[a]P has been analyzed most extensively. Sub-chronic (9 months) oral exposure of 
Xpa−/− mice resulted in an increased incidence and shorter latency time of lymphomas as 
compared with WT mice [65] and [130]. In accordance, in the spleen of Xpa-deficient mice, 
mutant frequency levels of the non-transcribed lacZ as well as the actively transcribed Hprt 
gene clearly exceeded those measured in WT mice [130], [131] and [132]. This increase in 
Hprt gene mutation in Xpa−/− mice was also observed upon exposure to BNU [133]. 
Interestingly however, exposure to high levels of BNU resulted in Hprt mutation levels similar 
to WT mice, suggesting that cell death was induced as a result of excessive DNA damage.  
Like carcinogen-induced tumor responses found in liver and bladder, the carcinogenic 
responses in the spleen of Csb−/− mice upon B[a]P exposure were low and similar to WT mice 
[134]. Also levels of mutations in the lacZ gene were not different from WT mice. In contrast, 
the mutant frequency in the Hprt gene was clearly elevated, which suggests that Csb-deficient 
cells are not capable to remove B[a]P adducts from actively transcribed genes, whereas DNA 
damage at non-transcribed sequences is removed as demonstrated by the lacZ mutant 
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis Volume 614, Issues 1-2 , 3 January 2007, Pages 77-94 
frequency data. As Csb−/− mice are not tumor prone upon B[a]P exposure, the Hprt gene 
mutation analyses do not predict tumor outcome in Csb-deficient mice.  
3.5. Lung 
Next to lymphomas, B[a]P also induces lung tumors in Xpa-deficient mice [135], however 
tumors are only found upon intra-tracheal exposure. No increased incidence of lung tumors 
was found when B[a]P was administered orally [132], not even in combination with cell 
proliferation induced by ozone [136]. These studies clearly demonstrate that the route of 
exposure determines which specific tissue will be affected. B[a]P exposure through the diet 
resulted in the development of predominantly fore-stomach tumors, gavage administration in 
lymphomas, and tracheal instillation in lung tumors. Like Xpa−/− mice, Xpc−/− mice are also 
more sensitive than WT mice to develop lung tumors. After N–OH–AAF treatment by a single 
i.p. injection, increased lung neoplasia was found in Xpc−/− mice [127], again demonstrating 
that dose regimens are determinant for tumor target sites as 2-AAF exposure through the diet 
did not result in lung tumor formation [126].  
3.6. Other sites 
Within the framework of the International Life Sciences Institute (ILSI)/Health and 
Environmental Sciences Institute (HESI), a large number of exposure experiments have been 
performed with Xpa−/− mice to validate this model as an alternative for the chronic 2-year 
cancer bio-assay. In general, Xpa−/− mice are susceptible to develop genotoxic carcinogen-
induced tumors [137]. Intriguingly, also some non-genotoxic human carcinogens were tested 
positive in the Xpa-model, like the hormone DES (pituitary and testis adenomas), the 
immunosuppressive agent cyclosporin-A (lymphomas) and the peroxisome proliferator WY-
14,643 (liver tumors). At present it is not clear why Xpa−/− mice are sensitive to these non-
genotoxic carcinogens. Furthermore, it remains to be elucidated whether the other GG-NER 
deficient mice like Xpc and Xpe have comparable phenotypes.  
4. Concluding remarks 
In general mouse models with defects in NER-related genes recapitulate human syndromes. 
These range from clear cancer proneness up to segmental premature aging features. Defects 
in GG-NER lead both in mice and man to cancer prone phenotypes. An interesting 
observation is that the spontaneous tumor spectra in GG-NER-defective mice are dependent 
on which gene is affected. Apparently, factors directly involved in damage recognition (XPC 
and XPE) have different substrate specificities and are possibly, next to NER, also involved in 
other DNA damage responses. For instance, in Xpc−/− mice a high incidence of lung tumors 
was found, which were absent in Xpa−/− mice. Possibly, lung specific (oxidative) DNA damage 
is specifically recognized by the XPC protein, whereas the XPA protein is not involved. In 
contrast to Xpc−/− mice, Xpa-deficient mice are susceptible to develop spontaneous liver 
tumors. Further studies are needed to get more knowledge on these tissue specificities.  
Defects in TC-NER in humans are associated with Cockayne syndrome (CS), which is 
characterized by UV-sensitivity, but interestingly not with skin tumor development. TC-NER 
prevents acute toxic effects by releasing stalled RNA polymerases, which are blocked by 
(bulky) DNA lesions in actively transcribed genes. Stalled RNA polymerases trigger p53-
dependent apoptosis and as such possibly contribute to an anti-cancer phenotype. Chemical 
exposure studies, with TC-NER defective mice, seem to support this vision, as Csb−/− mice 
are not susceptible to develop carcinogen-induced internal tumors. However, Csa−/−, Csb−/− 
and XpdTTD mice do develop skin tumors upon exposure to UV-B. Possibly, GG-NER is far 
less efficient in mice than in humans to remove UV-induced CPD lesions. Apparently, this 
does not hold for other bulky lesions. More mechanistic studies are necessary to elucidate 
why a TC-NER defect in mice leads to UV-induced skin cancer, but not in humans.  
In general gene mutation induction precedes tumor development in (NER-deficient) mice. It 
appears that mutations in the lacZ reporter gene are more reliable early markers for tumor 
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development in a particular tissue than, e.g. the endogenous actively transcribed Hprt gene. 
Enhanced lacZ mutations reflect genotoxic stress in a wide variety of tissues, however, they 
do not always predict cancer risk in a quantitative manner. In liver and spleen lacZ mutation 
levels correlate quite well with spontaneous as well as chemical-induced tumors, but this 
correlation is lacking in bladder, lung, and other tissues. Possibly, the cells in which mutations 
are detected (probably irreversibly differentiated somatic cells), are not the precursor initiated 
cells that progress to (malignant) tumors at later stages.  
In this review we showed that mice with a defect in NER are subject to various mutagenic and 
carcinogenic responses in different tissues. These responses depend on which sub-pathway 
of NER is defect and on which tissue is targeted either by endogenous or exogenous 
genotoxic compounds. However, some components of NER also contribute to other biological 
pathways, like transcription and ICL repair. Mice, but also humans, with defects in these 
genes (XpdTTD, Ercc1, Xpf and some Xpg variants) have in general (very) short life spans, 
display segmental progeria and are less or not cancer prone (see Table 1). Further studies 
are needed to dissect the individual roles of these specific pathways in the acceleration of the 
aging process and their contemporary tumor suppressive mode of action. Especially, it is far 
from clear yet what the nature is of the endogenous DNA lesions, which cause the severe 
phenotypes. Furthermore, the interplay between defective DNA repair systems, cellular 
senescence, stem cell depletion and apoptosis during aging need further attention.  
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